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Mammalian sex determination initiates in the fetal
gonadwith specification of bipotential precursor cells
into male Sertoli cells or female granulosa cells. This
choice was long presumed to be irreversible, but
genetic analysis in the mouse recently revealed that
sexual fates must be maintained throughout life. So-
matic cells in the testis or ovary, even in adults, can
be induced to transdifferentiate to their opposite-sex
equivalents by loss of a single transcription factor,
DMRT1 in the testis or FOXL2 in the ovary. Here, we
investigate what mechanism DMRT1 prevents from
triggering transdifferentiation. We find that DMRT1
blocks testicular retinoic acid (RA) signaling from
activating genes normally involved in female sex
determination and ovarian development and show
that inappropriate activation of these genes can drive
sexual transdifferentiation.Bypreventingactivationof
potential feminizinggenes,DMRT1allowsSertoli cells
to participate in RA signaling, which is essential for
reproduction, without being sexually reprogrammed.
INTRODUCTION
In mammals, gonadal sex is determined during fetal develop-
ment in the bipotential precursors of male Sertoli cells and
female granulosa cells (McClelland et al., 2012). If the Y chromo-
some gene Sry is expressed in the bipotential gonad during
a critical window of fetal development, it activates the related
Sox9 gene and triggers testis differentiation. Otherwise, a fe-
male-promoting regulatory network prevails and triggers ovary
differentiation. Despite this early cell fate commitment, genetic
studies in the mouse have shown that sexual fates in the gonad
must be actively maintained in both sexes throughout life. The
transcriptional regulators Dmrt1 and Foxl2 are essential for sex
maintenance in the postnatal testis and ovary, respectively.
Loss of either gene, even in the adult gonad, can trigger a dra-
matic transdifferentiation of cell fate involving extensive reprog-
ramming of sex-specific gene regulation (Matson et al., 2011;DeveUhlenhaut et al., 2009). Previous studies suggested mutual
antagonism between the two genes: loss of Dmrt1 in the adult
mouse testis activates Foxl2 expression, whereas loss of Foxl2
in the adult ovary activates Dmrt1 (Matson et al., 2011; Matson
and Zarkower, 2012; Uhlenhaut et al., 2009). Thus, Dmrt1 and
Foxl2 appear to anchor mutually antagonistic regulatory net-
works that lock in sexual differentiation and then continuously
maintain appropriate cell fates.
Previous genetic analysis clearly revealed the existenceofmale
and female sexual fate maintenance networks; however, the
functional composition of these networks is poorly understood.
In particular, it is unknown whether the regulatory mechanisms
that can cause Sertoli cells to transdifferentiate into granulosa
cells in the mutant testis are related to those that normally direct
granulosa cell differentiation in the fetal ovary. Moreover, the
physiological reasonwhysexual fatesmustbecontinuouslymain-
tained postnatally, long after they are specified, is unknown.
Here we address both questions. First, we use genetic ana-
lyses to ask which genes are functionally required in fate mainte-
nance and reprogramming of the testis. We show that DMRT1
maintains male sex postnatally in concert with the male fetal
sex determination gene Sox9 and that the feminizing genes it
must silence include components of the fetal sex determination
network. Our results therefore indicate that postnatal sex main-
tenance and transdifferentiation are mechanistically related to
fetal male and female sex determination. Second, although reti-
noic acid (RA) signaling between Sertoli cells and germ cells is
essential for mammalian spermatogenesis, we show that when
DMRT1 is absent, RA signaling also can activate genes that drive
male-to-female transdifferentiation. Thus, DMRT1 allows Sertoli
cells to participate in RA signalingwhile avoiding consequent cell
fate reprogramming. Our results reveal that cell signaling can
entail risk to the cell identities of the participants, andwe suggest
that other cell types likewise may require mechanisms to protect
against reprogramming.
RESULTS
Ectopic FOXL2 Drives Male-to-Female
Transdifferentiation in Dmrt1 Mutant Sertoli Cells
Dmrt1mutant Sertoli cells express FOXL2 early in transdifferen-
tiation, and chromatin immunoprecipitation results suggestedlopmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier Inc. 511
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Figure 1. Ectopic Foxl2 Drives Male-to-Female Transdifferentiation in Dmrt1 Mutant Testes
Immunofluorescence detection of SOX9 andGATA4 proteins in control andmutant adult gonads. Granulosa cells of control ovaries express GATA4 but not SOX9
(A), as do granulosa cells arising from postnatal transdifferentiation after Dmrt1 is deleted in fetal XY gonads with Sf1-cre (B). Green staining of oocytes in control
ovaries is a nonspecific antibody artifact; GATA4 also is expressed in interstitial Leydig cells outside the tubules. Deletion of Foxl2 together with Dmrt1 in XY
gonads (C) suppresses transdifferentiation; the resultant adult gonads have tubules with many Sertoli cells expressing abundant SOX9 adjacent to the tubule
periphery, similar to those of control testis (D), as well as germ cells negative for both SOX9 and GATA4. Red staining of elongated spermatids is a nonspecific
antibody artifact. Control gonads in this figure were from floxed animals lacking cre. Scale bars represent 20 mm. DAPI, 406-diamidino-2-phenylindole (a DNA
stain). Dashed lines indicate tubule periphery. See also Figure S1.
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natal testis (Matson et al., 2011). However, it is unknownwhether
the ectopic expression of FOXL2 is important for driving transdif-
ferentiation or is merely a consequence of activating transdiffer-
entiation. To distinguish between these possibilities, we deleted
Dmrt1 and Foxl2 in somatic cells of the fetal testis using Sf1-cre,
which is active in fetal pre-Sertoli cells around the time of sex
determination (Bingham et al., 2006; Lavery et al., 2011). To track
cell fates, we examined expression of SOX9, which is expressed
only in Sertoli cells, and GATA4, which is expressed in both Ser-
toli and granulosa cells. Loss of Foxl2 dramatically suppressed
feminization of adult Dmrt1 mutant testes: double mutant go-
nads retained GATA4/SOX9 double-positive Sertoli cells, lacked
GATA4 single-positive granulosa cells, and had seminiferous
tubules (Figure 1). Because DMRT1 is dispensable for mainte-
nance of male cell fate if Foxl2 is inactivated, we conclude that
ectopic Foxl2 does indeed drive female transdifferentiation.
Repression of Foxl2 cannot be the only function of DMRT1 in
postnatal Sertoli cells, however, because Dmrt1;Foxl2 condi-
tional mutant adult gonads had small seminiferous tubules and
severely disrupted spermatogenesis. We therefore examined
additional markers. In addition to SOX9, the Sertoli cells in dou-
ble mutants expressed GATA1 (Figure S1 available online) and
double mutant testes also had highly elevated expression of
the Sertoli cell marker Sox8 relative to Dmrt1 single mutants
(16-fold qRT-PCR difference; p = 0.038, Student’s two-tailed t
test; two individuals of each genotype). However, double mutant
Sertoli cells appeared not to have completed polarization and
did not express androgen receptor (AR; Figure S1), which we
have shown is directly activated by DMRT1 (Murphy et al.,
2010). AR is required in Sertoli cells for support of spermatogen-
esis and its deletion in Sertoli cells disrupts germ cell meiotic pro-
phase (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and
Braun, 2004). Dmrt1;Foxl2 mutant testes had disrupted meiotic
prophase but also severely reduced numbers of spermatogonia,
so lack of AR expression in the mutant Sertoli cells can only
partially explain the spermatogenesis defect. We conclude that
Dmrt1 is essential in the postnatal testis to prevent male-to-
female (Sertoli-to-granulosa) transdifferentiation and for full
Sertoli cell differentiation and function.512 Developmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier InEctopic Estrogen Signaling and Wnt/b-Catenin
Signaling Drive Male-to-Female Transdifferentiation in
Dmrt1 Mutant Testes
Like Foxl2, the estrogen receptors Esr1 and Esr2 help maintain
female sex (Couse et al., 1999) and cooperate with Foxl2 to
repress Sox9 transcription in granulosa cells (Uhlenhaut et al.,
2009). Loss of Dmrt1 in Sertoli cells activates Esr1, Esr2, and
the estrogenic enzyme CYP19A1/Aromatase, and Dmrt1mutant
males have elevated serum estradiol (Matson et al., 2011).
To test whether this ectopically activated estrogen signaling
promotes male-to-female transdifferentiation, we examined XY
mice carrying null mutations in Dmrt1 and each estrogen recep-
tor (ER). Loss of Esr1 had no effect on feminization of Dmrt1
mutant gonads (Figures S2A, S2B, and S2E) but loss of Esr2
greatly reduced feminization in animals heterozygous or null for
Esr1 (Figures 2A–2D; Figures S2C and S2E). We conclude that
estrogen signaling is an important driver of transdifferentiation
when Dmrt1 is lost. Based on our results, ERb (encoded by
Esr2) is clearly important for transdifferentiation. However,
becausewewere unable to obtainDmrt1;Esr2mutantmales fully
wild-type for Esr1, it remains possible that there is some func-
tional redundancy between ERa and ERb. Dmrt1 mutant testes
lacking both estrogen receptors were still partially feminized
(Figure S2D), suggesting that another feminizing pathway
remained active. Together with the Dmrt1;Foxl2 mutant pheno-
type described above, the requirement for Esr2 demonstrates
that the female sex maintenance network drives transdifferentia-
tion when ectopically activated in males.
In the fetal gonad, female primary sex determination is
controlled by a WNT signaling pathway in which the WNT4 and
RSPO1 ligands signal through the b-catenin transcription factor.
Loss ofWnt4 orRspo1 in XX fetal gonads causes female-to-male
sex reversal, whereas constitutively active b-catenin can trigger
male-to-female sex reversal in the XY fetal gonad (Chassot et al.,
2008; Kim et al., 2006; Maatouk et al., 2008). DMRT1 represses
transcription of Wnt4 and Rspo1 in the postnatal testis (Matson
et al., 2011). To investigate whether ectopically activated WNT
signaling in Dmrt1 mutant testes promotes transdifferentia-
tion, we conditionally deleted Dmrt1 and b-catenin (encoded
byCtnnb1) in fetal pre-Sertoli cells using Sf1-cre. Loss ofCtnnb1c.
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Figure 2. Activated Estrogen Signaling and
Wnt/b-Catenin Signaling Drive Male-
to-Female Transdifferentiation in Dmrt1
Mutant Testes
(A–F) Immunofluorescence detection of SOX9
and FOXL2 proteins in control and mutant adult
gonads. Granulosa cells in wild-type (WT) ovaries
express abundant FOXL2 (A), asdoelongated theca
cells surrounding follicles. As in Figure 1, green
stainingofoocytes isa nonspecificantibodyartifact.
In wild-type testes (B), only SOX9-positive Sertoli
cells are present. In males, homozygous deletion of
Dmrt1 (in this case with loss of one copy of Esr2; C)
causes postnatal transdifferentiation of most Sertoli
cells into morphologically distinct FOXL2 positive
granulosa-like cells. Deletion of Esr2 and one copy
of Esr1 in males of the same genotype suppresses
this feminization, and many more SOX9-positive
Sertoli cells are present (D). Adult males condition-
ally mutant for Dmrt1 in Sertoli cells are almost fully
feminized (E), but conditional deletion of the b-cat-
enin gene Ctnnb1 together with Dmrt1 using the
same Sf1-cre transgene strongly suppresses the
feminization (F).
(G) qRT-PCR showing reduced expression of
feminizing gene mRNAs in Dmrt1;Foxl2 conditional
double mutant testes relative to expression in
Dmrt1 single mutant testes. Data are averaged
from replicate analysis of two animals of each
genotype; error bars are SD; degree of feminiza-
tion can vary between Dmrt1 mutants, but loss of
Foxl2 reduced expression of feminizing genes
below that seen in Dmrt1 mutants.
Scale bars represent 20 mm. See also Figure S2.
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(Figure 2F; Figure S2F). We also deleted Dmrt1 and Ctnnb1
with Dhh-cre, which is active in differentiating fetal Sertoli cells
(Bitgood et al., 1996) and observed the same phenotype (not
shown). Thus, at least part of the female sex determination
network is activated by loss of Dmrt1, suggesting that transdif-
ferentiation of postnatal Sertoli cells is mechanistically related
to normal fetal specification of ovarian cells. The residual femini-
zation in Dmrt1;Ctnnb1 double mutant gonads suggests that
other genes repressed by Dmrt1 can promote feminization inde-
pendently of b-catenin.
Reciprocal Regulation of Feminizing Genes
As shown earlier, loss of Foxl2 more completely suppresses
feminization of Dmrt1 mutants than loss of Esr1/2 or Ctnnb1.
To investigate whether Foxl2 is an upstream activator of other
feminizing genes, we examined their expression in Dmrt1;Foxl2
double mutant testes. We found thatDmrt1;Foxl2 double mutant
testes had greatly reduced expression of the granulosa marker
Lrh1 as well as Esr2 and Wnt4 and slightly reduced expression
of Esr1 relative to Dmrt1 single mutants (Figure 2G). This result
suggests that ectopic Foxl2 expression in the testis activates es-
trogen signaling andWnt signaling. In addition, the loss of FOXL2
expression in Dmrt1;Esr1/2, and Dmrt1;Ctnnb1 mutant testes
(Figures 2D and 2F) indicates that estrogen signaling and Wnt
signaling also regulate Foxl2. Thus, the female regulatory
network activated by loss ofDmrt1 involves significant reciprocal
regulation.DeveDMRT1 Acts with SOX9 to Maintain Male Gonadal Cell
Fates
Given the apparent role of female sex-determining genes in
transdifferentiation, we investigated whether these genes are
opposed in the postnatal testis by the male fetal sex determina-
tion network. Sox9 plays a central role in male fetal sex determi-
nation: its expression in the early fetal gonad is both necessary
and sufficient for male development (Chaboissier et al., 2004;
Lavery et al., 2011; Qin et al., 2004; Vidal et al., 2001). Sox9 is
dispensable for male fates after sex determination (Barrionuevo
et al., 2009; Chang et al., 2008). However, we found that Sox9
is partially redundant with Dmrt1 in postnatal sex maintenance:
deleting Sox9 together with Dmrt1 after sex determination using
Dhh-cre enhanced transdifferentiation (Figure 3). The start of
transdifferentiation was unaffected in double mutants, beginning
around postnatal day 8 (P8) in both Dmrt1 and Dmrt1;Sox9
mutant testes (Figures 3A and 3D). However, by P14, the
Dmrt1;Sox9mutant gonads had considerably more FOXL2-pos-
itive cells and by 5 weeks virtually all Sertoli cells had transdiffer-
entiated (Figures 3B, 3C, 3E, and 3F). The involvement of Sox9
suggests that male sex maintenance, like transdifferentiation,
is mechanistically related to normal fetal sex determination.
Enhanced RA Signaling Accelerates
Transdifferentiation in Dmrt1 Mutant Testes
Maintenance of gonadal cell fates requires sustained activity
of sex maintenance networks throughout postnatal life (Matson
et al., 2011; Uhlenhaut et al., 2009). It is not obvious why fullylopmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier Inc. 513
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Figure 3. DMRT1 and SOX9 Act Together to Maintain Male Fates
(A–F) Immunofluorescence detection of the Sertoli cell marker SOX8 and
granulosa cell marker FOXL2 in control and conditional mutant adult gonads.
Deletion of Dmrt1 with Dhh-cre in the XY fetal gonad after sex determination
causes transdifferentiation with FOXL2 expression beginning around P8 (A).
Transdifferentiation is still quite limited at P14 (B), and apparent inmany but not
all intratubular somatic cells by 5 weeks (C). XY gonads with both Dmrt1 and
Sox9 deleted with Dhh-cre have similar numbers of FOXL2 positive cells
present at P8 (D), butmanymore at P14 (E) and 5weeks (F) compared toDmrt1
single mutant gonads. Scale bars represent 20 mm.
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uous protection. Sertoli cells surround and support germ cells
and the two cell types communicate via varied paracrine
signaling interactions that facilitate reproduction; we hypothe-
sized that one or more of these signaling interactions might
have potential to reprogram Sertoli cell fate if DMRT1 is not
present.
In particular, we considered a possible role for RA signaling,
based in part on the timing of the transdifferentiation phenotype.
RA is essential for aspects of spermatogenesis including
spermatogonial differentiation and spermiation (Hasegawa and
Saga, 2012; Raverdeau et al., 2012; van Pelt and de Rooij,
1990) and is a potent cell fate inducer during development (Rhinn
and Dolle´, 2012). Strikingly, RA from neonatal Sertoli cells trig-
gers spermatogonial differentiation during the first postnatal
week, close to when transdifferentiation starts in Dmrt1 mutant
testes (Raverdeau et al., 2012). RA also influences cyclical
gene expression in adult Sertoli cells during steady state sper-
matogenesis and promotes differentiation of cultured juvenile
Sertoli cells (Hasegawa and Saga, 2012; Nicholls et al., 2013;
Sugimoto et al., 2012; Vernet et al., 2006). We found previously
that DMRT1 limits RA signaling in spermatogonia to promote
spermatogonial differentiation and control the mitosis-to-
meiosis switch (Matson et al., 2010). We therefore considered
that DMRT1 also might limit RA response in Sertoli cells.
We first tested the prediction that elevated RA enhances
transdifferentiation. We injected the RA precursor retinol acetate
(ROL) at P4 into Dmrt1 conditional mutant pups deleted with
Dhh-Cre and examined their gonads at P14, a time when trans-
differentiation is just starting in untreated Dmrt1 mutant testes.
ROL injection in wild-type did not affect Sertoli cell fates (Figures
4A and 4D), but ROL injection of Dmrt1 mutants strongly
enhanced feminization relative to vehicle-injected controls (Fig-
ures 4B and 4C).514 Developmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier InReduced RA Signaling Suppresses Transdifferentiation
in Dmrt1Mutant Testes
If RA signaling stimulates transdifferentiation, as suggested
by the ROL injections, then reducing RA levels in Dmrt1mutants
should suppress the process. We confirmed this prediction us-
ing two strategies. First, to block intratubular RA synthesis, we
treated neonates with the retinaldehyde dehydrogenase inhibitor
WIN 18,446 (Amory et al., 2011; Hogarth et al., 2011, 2013). Pups
conditionally deleted for Dmrt1 in Sertoli cells with Sf1-cre were
treated with WIN 18,446 or vehicle daily from P2 to P21 and then
the extent of transdifferentiation was assessed. In contrast to
vehicle-treated mutant testes that were extensively feminized
at P21, those from WIN 18,446-treated mutants had virtually
no FOXL2-positive granulosa cells andmany SOX9-positive Ser-
toli cells (Figures 4E–4H). As a second approach to reduce RA
levels, we used dietary vitamin A depletion (VAD), placing preg-
nant females on vitamin A deficient chow and maintaining their
pups on this chow until adulthood (Figures 4I–4L). RA is essential
for spermatogonial differentiation; consequently VAD wild-type
adult males had normal Sertoli cells but very few germ cells, con-
firming the effectiveness of the depletion (Figures 4I and 4L). In
Dmrt1 mutant VAD adult males feminization was strongly sup-
pressed relative to vitamin A sufficient (VAS) mutants (Figures
4J and 4K). In summary, increasing RA enhanced transdifferen-
tiation, whereas reducing RA levels by two different methods
suppressed transdifferentiation of Dmrt1 mutant testes. We
conclude that RA can stimulate transdifferentiation and that
DMRT1 normally blocks its ability to do so.
Loss of RARa in Sertoli Cells Suppresses
Transdifferentiation
Next, we examined the role of retinoic acid receptors (RAR) in
transdifferentiation. To test which receptor mediates transdiffer-
entiation, we used conditional alleles of the two predominant
RAR-encoding genes of Sertoli cells and spermatogonia, Rara
and Rarg, as well as the third RAR-encoding gene Rarb (Chapel-
lier et al., 2002a, 2002b, 2002c). We deleted Dmrt1 together with
each receptor gene in somatic cells of the fetal gonad using
Sf1-Cre or Dhh-Cre and assessed transdifferentiation in double
mutant testes. Deletion of Rara with Dmrt1 strongly suppressed
feminization (Figures 5A and 5B), whereas deletion of Rarb or
Rarg plus Dmrt1 had no discernible effect on transdifferentiation
(Figures 5C–5E). Deleting Rara with either Sf1-Cre (Figure 5B) or
the Sertoli-specific Dhh-Cre (not shown) suppressed feminiza-
tion, confirming that RA acts directly on Dmrt1 mutant Sertoli
cells. Sertoli cells lacking Dmrt1 and one copy of Rara were
less feminized than Dmrt1 single mutants (Figure 5A versus
Figure 5C) or Dmrt1 mutants lacking one copy of Rarg (Fig-
ure 5E), suggesting that Rara may be partially haploinsufficient
for feminization. Collectively, our data indicate that retinoid
signaling, acting via RARa, plays an important role in promoting
Sertoli cell transdifferentiation in Dmrt1 mutants and that Dmrt1
is largely dispensable for sex maintenance in the absence of
retinoid signaling.
Germ Cells Are Not Required for Transdifferentiation in
Juvenile Testes
Both cell types inside the seminiferous tubules, Sertoli cells and
germ cells, are believed to produce RA during at least somec.
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Figure 4. Retinoid Signaling Promotes Transdifferentiation of Dmrt1 Mutant Sertoli Cells
(A–D) Retinol treatment enhances transdifferentiation. At P14, control testes from Dmrt1fl/+ animals injected with vehicle (PBS) had no FOXL2 positive trans-
differentiated cells (A) and vehicle-injected conditional mutants deleted with Dhh-Cre (B) had small numbers of FOXL2-positive transdifferentiated cells. Retinol
acetate (ROL) injection at P4 into conditional mutant testes resulted in many FOXL2 positive cells at P14 (C), whereas injection of ROL into control testes did not
induce transdifferentiation (D).
(E–H) Inhibition of RA synthesis suppresses transdifferentiation. At P21, testes ofDmrtfl/fl control animals (E) treated fromP5with vehicle (1%gum tragacanth) had
no FOXL2-positive transdifferentiated cells whereas vehicle-treated conditional mutants deleted with Sf1-Crewere extensively transdifferentiated (F). Treatment
of conditional mutants with WIN 18,446 almost completely suppressed transdifferentiation (G). Treatment of controls with WIN 18,446 disrupted spermato-
genesis (H), confirming that the RA synthesis was blocked.
(I–L) Dietary vitamin A depletion suppresses transdifferentiation. Relative to testes fromwild-type adult mice on vitamin A sufficient (VAS) diets (I), VAS adult testes
with Dmrt1 deleted using Sf1-cre (J) had many transdifferentiated cells expressing FOXL2. (Note that conditional loss of Dmrt1 in Sertoli cells also causes
postnatal germ cell loss.) Dietary vitamin A depletion of conditional Dmrt1 mutant mice, starting in utero, reduced the number of FOXL2 positive cells and
increased the number of SOX9 positive cells (K). VAD treatment of wild-type mice had no effect on Sertoli cell differentiation or maintenance, but blocked
spermatogonial differentiation, confirming the effectiveness of VAD and resulting in largely empty seminiferous tubules (L).
Scale bars represent 40 mm.
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Retinoic Acid and Sexual Transdifferentiationstages of development (Raverdeau et al., 2012). We tested
whether germ cells might contribute to transdifferentiation of
Dmrt1 mutants as sources of RA or other signaling molecules
by genetic ablation, using mutations in the germ cell survival fac-
tor c-kit. Dmrt1;kitW/Wv mutant testes were strongly feminized
despite lacking germ cells since prior to gonadal differentiation
(Figures 6A–6D), indicating that germ cells do not play a signifi-
cant role as a source of feminizing RA in the juvenile testis,
although we cannot exclude that germ cells play a role in
transdifferentiation caused by loss of Dmrt1 in adults (Matson
et al., 2011).
Intratubular RA Levels Appear Normal in Dmrt1 Mutant
Juvenile Testes
Our results indicate that DMRT1 prevents transdifferentiation
by somehow limiting RARa activity in Sertoli cells. DMRT1 might
inhibit RARa by limiting RA levels or by repressing transcription
of selected RARa targets. It is not feasible to directly assay RA
levels in Sertoli cells, but RA is freely diffusible between cellsDeve(Shimozono et al., 2013). Spermatogonia are extremely sensitive
to RA and thus can be used as sensors to ask whether Dmrt1
mutant Sertoli cells are producing excessive intratubular RA.
Two experiments examining spermatogonial gene expression
suggested that intratubular RA levels are not elevated in Dmrt1
mutant testes. First, we examined the RA-inducible gene
Stra8. RA from juvenile Sertoli cells normally triggers STRA8
expression in a subset of spermatogonia to initiate asynchro-
nous spermatogenesis (Raverdeau et al., 2012), and RA supple-
mentation in neonates can activate strong STRA8 expression in
virtually all juvenile spermatogonia, demonstrating that they are
very sensitive to RA during this period (Davis et al., 2013; Snyder
et al., 2011). Dmrt1 mutant juvenile testes have reduced
numbers of spermatogonia, but deletion of Dmrt1 in Sertoli cells
did not increase the proportion of spermatogonia that were
strongly STRA8-positive or the proportion of tubules containing
STRA8-positive germ cells (Figures 6E–6H). Second, we exam-
ined expression of the RA-responsive transcriptional reporter
gene RAREhsplacZ (Rossant et al., 1991). This reporter doeslopmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier Inc. 515
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Figure 5. RARa, but Not RARb or RARg, Is Required for Transdiffer-
entiation
Immunofluorescence detection of SOX9 and FOXL2 proteins in adult testes.
Conditional deletion of Dmrt1 with one copy of Rara using Sf1-Cre caused
strong transdifferentiation (A), whereas deletion of Dmrt1 and both alleles of
Rara with Sf1-Cre strongly suppressed transdifferentiation (B), indicating that
Rara is required. In contrast, deletion ofDmrt1 alone orwithRarb usingSf1-Cre
(C and D) or deletion of Dmrt1 with one (E) or both (F) alleles of Rarg using
Dhh-Cre caused transdifferentiation, indicating that Rarb and Rarg are not
required for transdifferentiation of Dmrt1 mutant Sertoli cells. Scale bars
represent 80 mm.
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Retinoic Acid and Sexual Transdifferentiationnot express in Sertoli cells but is exquisitely sensitive to RA
signaling in spermatogonia (Matson et al., 2011; Snyder et al.,
2011). RAREhsplacZ expression in wild-type and Dmrt1 mutant
testes, like STRA8, was high only in a subset of spermatogonia
regardless of their proximity to mutant Sertoli cells (Figures
S3A–S3F). We also examined mRNA expression profiling data
from P9 testes conditionally deleted for Dmrt1 in Sertoli cells
(Murphy et al., 2010) and these showed no significant misregula-
tion of RA pathway genes and no increase in expression of
known RA-inducible genes. From these results, we conclude
that DMRT1 in Sertoli cells does not function to limit the level
of intratubular RA. Instead, we favor alternative models in which
DMRT1 restricts RARa activity in Sertoli cells without regulating
RA levels.
Retinoid Signaling Activates Expression of Feminizing
Genes if DMRT1 Is Absent
In principle, RARa could act upstream to activate some or all of
the feminizing genes, or it could instead act in parallel to those
genes to promote transdifferentiation. If RARa acts upstream516 Developmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier Inof feminizing genes, then their expression should be reduced
in VAD Dmrt1 mutants; in contrast, if RARa acts in parallel to
the feminizing genes, VAD mutants should retain elevated
expression of feminizing genes but maintain male fates because
RARa is not able to cooperate with the feminizing genes. VAD
treatment reduced expression of Foxl2, Lrh1, Esr2, and Wnt4
mRNAs (Figure 6I) in Dmrt1 mutant testes, indicating that RAR
does act upstream to promote expression of feminizing mRNAs
when Dmrt1 is missing. We suggest that DMRT1 silences inap-
propriate RARa target genes that can transform sexual cell
fate, while permitting RARa-dependent expression of appro-
priate target genes that are essential for Sertoli cell differentiation
and for support of spermatogenesis. We note, however, that it
remains possible that RARa also synergizes with the feminizing
genes to promote transdifferentiation once they are activated
(see Discussion).
DISCUSSION
Here we have found that DMRT1 is required to prevent RA
signaling from promoting reprogramming of Sertoli cells to gran-
ulosa cells in the postnatal testis. RA signaling is essential for
male gametogenesis and has been implicated in Sertoli cell dif-
ferentiation; however, we found that RA also can activate genes
of both the female sex maintenance network and the female sex
determination network if DMRT1 is absent from Sertoli cells. We
found previously that DMRT1 binds to chromatin near many of
the key feminizing genes identified here, including Foxl2 and
Esr2 (Matson et al., 2011). Thus, the simplest model for sexual
fate maintenance is that DMRT1 and RARa are antagonistic reg-
ulators of feminizing genes whose inappropriate expression in
the testis can cause transdifferentiation. By silencing this subset
of RARa targets, DMRT1 allows Sertoli cells to participate in the
RA signaling that is essential for spermatogenesis while avoiding
transdifferentiation (diagrammed in Figure 7).
Whereas the ability of RA to activate feminizing genes when
DMRT1 is missing indicates a role for RARa upstream of the
feminization network and in parallel to DMRT1, studies of
RARa in other contexts suggest that it may also act together
with the feminizing genes to cooperatively regulate gene
expression. For example, ER and RARa are nuclear hormone
receptors that cooperate to bind DNA and regulate gene
expression in breast cancer cells, with ER recruiting RARa at
many target genes (Ross-Innes et al., 2010). We suggest that
ER and RARamay cooperate by a similar molecular mechanism
in Dmrt1mutant Sertoli cells to promote female transdifferentia-
tion. ER also can be recruited to many cell type-specific sites by
‘‘tethering’’ to a variety of transcription factors (Gertz et al.,
2013). Similarly, b-catenin can physically interact with RARa
and other nuclear hormone receptors that are ectopically ex-
pressed in Dmrt1-mutant Sertoli cells including ER and LRH1,
and it can serve as an nuclear hormone receptor coactivator
(Mulholland et al., 2005). We found that the feminizing genes
could mutually activate each other’s expression. This reciprocal
regulation and the potential for synergistic function once they
are expressed suggest that the critical feminizing genes we
have identified may functionally cooperate in a complex regula-
tory web. It will be important in future work to examine in detail
the physical interactions, DNA binding, and gene regulatoryc.
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Figure 6. Feminizing RA Is Not Produced byGermCells and Appears
to Be at Normal Levels
(A–D) Germ cells are not required for transdifferentiation of Dmrt1 mutant
Sertoli cells. Deletion of Dmrt1 causes most SOX9-positive Sertoli cells (A) to
transdifferentiate into FOXL2 positive granulosa cells (B). Loss of c-kit function
eliminates virtually all germ cells during fetal development, leaving seminifer-
ous tubules containing only differentiated SOX9-positive Sertoli cells in Dmrt1
heterozygous control testes (C). Testes ofDmrt1 homozygous kitW/Wv mutants
were extensively feminized despite lacking germ cells (D). (Gonads in A–D
were from adults.)
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Devefunctions of these proteins in the context of Sertoli cell
transdifferentiation.
Genetic analysis demonstrated that several genes normally
involved in female sex determination and ovarian differentia-
tion are critical for transdifferentiation in the testis when they
are inappropriately activated by RARa. This suggests a mech-
anistic link between the normal specification and differentiation
of granulosa cells in the fetal and postnatal ovary and Sertoli-
to-granulosa transdifferentiation in the postnatal testis. Simi-
larly, the involvement of Sox9 in sex maintenance suggests a
link between male sex maintenance and male fetal sex deter-
mination. There are important differences in how Sertoli cell
transdifferentiation and normal granulosa cell differentiation
are regulated, but our data make it clear that transdifferentia-
tion occurs by a process related to normal ovarian differentia-
tion. This link between transdifferentiation and normal female
development may answer an important question: why do femi-
nizing genes remain potential RARa targets in the testis when
their inappropriate activation in the testis is highly deleterious
to reproduction? An attractive possibility is that this represents
a sexual conflict: if RAR promotes granulosa cell differentiation
in the fetal ovary by activating these feminizing genes, then
their capacity for regulation by RAR (with the attendant risk
to male reproduction) must be maintained to allow female
reproduction.
In addition to DMRT1, other sexual regulators implicated in
this study as controlling postnatal sexual fates are conserved
in gonadal regulation in other vertebrates (e.g., SOX9, ER, and
FOXL2), raising the possibility that the process is conserved
outside mammals. This appears to be the case in fish: loss
of Dmrt1 causes male-to-female sexual transdifferentiation in
medaka (Masuyama et al., 2012), whereas disruption of estro-
gen signaling with the aromatase inhibitor fadrazole can cause
female-to-male transdifferentiation in Nile tilapia (Sun et al.,
2014). It is unknownwhether sexual transdifferentiation in fish in-
volves RA signaling, but the possibility should be investigated,
because RA signaling recently has been suggested to play a
role in normal gonadal development and/or gametogenesis in
zebrafish (Rodrı´guez-Marı´ et al., 2013). Homologs of DMRT1
also regulate sex in many other metazoans (Matson and
Zarkower, 2012) and it will be important to determine whether
sex maintenance is conserved outside vertebrates.
In the past decade, much progress has been made in artifi-
cially reprogramming cell fates. It is now possible, by forced
expression of defined sets of transcription factors and/or
miRNAs, to achieve direct cell fate conversion in culture(E–H) Loss of Dmrt1 in Sertoli cells does not induce STRA8 expression in
spermatogonia. Expression of RA-inducible germ cell marker STRA8 and
spermatogonial marker TRA98 in juvenile (P8) testes. In wild-type testes (E and
G), a subset of tubules contain germ cells with abundant STRA8 expression,
reflecting the asynchronous initiation of spermatogenesis that is triggered
by RA from Sertoli cells at this stage. When Dmrt1 is deleted in Sertoli cells
(F and H), there is no obvious increase in the proportion of germ cells ex-
pressing STRA8, suggesting that intratubular RA levels are not elevated (RA is
freely diffusible between cells).
(I) qRT-PCR showing reduced expression of feminizing gene mRNAs in VAD
Dmrt1 mutants relative to VAS Dmrt1 mutants. Results are from replicate
analysis of two animals of each condition.
Error bars represent SD. See also Figure S3.
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Figure 7. Model for Role of DMRT1 in Sex Maintenance
DMRT1 directly represses transcription in Sertoli cells of potential feminizing
genes including Foxl2, Esr2, and the Wnt/b-catenin pathway genes Wnt4
and Rspo1 (Matson et al., 2011). This model shows that DMRT1 thereby
allows Sertoli cells to produce RA that is necessary for spermatogenesis
without causing RARa to activate these feminizing genes. The model also
indicates that it is possible, based on data from other systems, that RARa
synergizes with products of some of the feminizing genes to drive trans-
differentiation. In addition to the genes shown, DMRT1 also represses
Cyp19a1/aromatase, which makes estradiol that stimulates ER activity
(Matson et al., 2011).
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et al., 2013). However, reports of in vivo cell fate reprogramming
resulting from altered expression of one gene are still quite rare
and the reasons are unclear (Cobaleda et al., 2007; Holmberg
and Perlmann, 2012; Johnson et al., 2008). Are Sertoli and gran-
ulosa cells unusual in being readily interconvertible or is such
plasticity more widespread but poorly recognized? Although
they are morphologically very different, Sertoli and granulosa
cells derive from a common bipotential progenitor and they
may retain epigenetic and other similarities. Thus, one possibil-
ity is that their barrier to transdifferentiation is unusually
low. However, it is also possible that other cell types are poten-
tially interconvertible and require active maintenance to pre-
vent transdifferentiation, whether in response to RA or other
signaling molecules.
Detecting a role for a regulatory gene in cell fate maintenance
can require allowing differentiation to be completed and then
conditionally inactivating the gene, which is not a test that is
routinely performed. Moreover, RA functions during and after
development in many tissues (Rhinn and Dolle´, 2012). We
therefore speculate that additional mammalian cell types might
require active protection from transdifferentiation triggered by
RA or possibly other potent signaling molecules, and that the
critical genes maintaining their fates await discovery. There is
some evidence for this possibility. In the pancreas, for example,
ablation of beta cells causes an apparent alpha-to-beta transdif-
ferentiation (Thorel et al., 2010), although the signals responsible
and the genetic mechanism by which the alpha cell fate is main-
tained in the presence of beta cells have yet to be defined.
Candidate regulators of cell fate maintenance include not only
other DMRT transcription factors (Matson and Zarkower,
2012), but also homeobox transcription factors (Johnson et al.,
2008). Because the gonad is dispensable for viability and has
highly plastic differentiated cells, it may provide a useful model
for understanding mechanisms of cell fate maintenance and
transdifferentiation and for developing strategies to artificially
reprogram other cell types in vivo.518 Developmental Cell 29, 511–520, June 9, 2014 ª2014 Elsevier InEXPERIMENTAL PROCEDURES
Mouse Breeding
Mice were of mixed C57BL/6J and 129Sv genetic background. Genotyping
was performed as described (Chaboissier et al., 2004; Chapellier et al.,
2002a, 2002b, 2002c; Uhlenhaut et al., 2009; and http://jaxmice.jax.org).
Experimental protocols were approved by the University of Minnesota Institu-
tional Animal Care and Use Committee.
Vitamin A Depletion and Retinol Injection
Dietary vitamin A depletion was performed as described (Matson et al., 2010;
van Pelt and de Rooij, 1990). The retinaldehyde dehydrogenase inhibitor WIN
18,446 (gift of C. Hogarth and M. Griswold) was administered by pipette
feeding of 100 ug/g body weight WIN 18,446 in 1% gum tragacanth, as
described (Hogarth et al., 2013). For retinol supplementation, 100 ul retinol-
acetate (2.5 mg/ml in PBS) was injected intraperitoneally at P4.
mRNA and Protein Expression Analysis
mRNA extraction, cDNA synthesis, qRT-PCR, immunofluorescence, and
immunohistochemistrywere performedasdescribed (Matson et al., 2010). Anti-
bodies and dilutions are listed in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2014.04.017.
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